Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$WSM Williams-Sonoma: William Blair Analyst Recommends Investors To Establish Or Add To Positions On This Pullback http://www.smarteranalyst.com/2014/08/29/williams-sonoma-william-blair-recommends-investors-to-establish-or-add-to-positions-on-this-pullback/
$OVTI Wedbush Maintains Neutral On OmniVision, Increases PT To $28 http://www.smarteranalyst.com/2014/08/29/wedbush-maintains-neutral-on-omnivision-increases-pt-to-28/
$OVTI Wedbush Maintains Neutral On OmniVision, Increases PT To $28 http://www.smarteranalyst.com/2014/08/29/wedbush-maintains-neutral-on-omnivision-increases-pt-to-28/
$WDAY Workday: Long-Term Fundamentals Remain Very Much In Place, Says William Blair http://www.smarteranalyst.com/2014/08/29/workday-long-term-fundamentals-remain-very-much-in-place-says-william-blair/
$WDAY Workday: Long-Term Fundamentals Remain Very Much In Place, Says William Blair http://www.smarteranalyst.com/2014/08/29/workday-long-term-fundamentals-remain-very-much-in-place-says-william-blair/
$DG Dollar General Has Significant Organic Growth Potential In New And Existing Markets, Says Wedbush http://www.smarteranalyst.com/2014/08/29/we-believe-the-company-still-has-significant-organic-growth-potential-in-new-and-existing-markets-says-wedbush/
Dollar General Has Significant Organic Growth Potential In New And Existing Markets, Says Wedbush http://www.smarteranalyst.com/2014/08/29/we-believe-the-company-still-has-significant-organic-growth-potential-in-new-and-existing-markets-says-wedbush/
$SPLK Splunk’s Fiscal Second Quarter Results - A Scare For The Bears, Says UBS http://www.smarteranalyst.com/2014/08/29/splunks-fiscal-second-quarter-results-a-scare-for-the-bears-says-ubs/
Splunk’s Fiscal Second Quarter Results - A Scare For The Bears, Says UBS http://www.smarteranalyst.com/2014/08/29/splunks-fiscal-second-quarter-results-a-scare-for-the-bears-says-ubs/
Roth Capital Maintains Neutral On Pacific Sunwear Following Second Quarter Results http://www.smarteranalyst.com/2014/08/29/roth-capital-maintains-neutral-on-pacific-sunwear-following-second-quarter-results/
$EDAP H.C. Wainwright Reiterates Buy On EDAP Following 2Q14 Update http://www.smarteranalyst.com/2014/08/28/h-c-wainwright-reiterates-buy-on-edap-following-q214-update/
$EDAP H.C. Wainwright Reiterates Buy On EDAP Following 2Q14 Update http://www.smarteranalyst.com/2014/08/28/h-c-wainwright-reiterates-buy-on-edap-following-q214-update/
Cowen Reaffirms Market Perform On Baxter Following Release Of BAX 855 Phase III Data http://www.smarteranalyst.com/2014/08/28/cowen-reaffirms-market-perform-on-baxter-following-release-of-bax-855-phase-iii-data/
Roth Capital Maintains Buy On Vapor’s Shares, $6 PT http://www.smarteranalyst.com/2014/08/28/roth-capital-maintains-buy-on-vapors-shares-6-pt/
$TIF Tiffany: Shares Are Already Pricing In A Healthy Dose Of Optimism, Says Canaccord http://www.smarteranalyst.com/2014/08/28/tiffany-shares-are-already-pricing-in-a-healthy-dose-of-optimism-says-canaccord/
$TIF Tiffany: Shares Are Already Pricing In A Healthy Dose Of Optimism, Says Canaccord http://www.smarteranalyst.com/2014/08/28/tiffany-shares-are-already-pricing-in-a-healthy-dose-of-optimism-says-canaccord/
$ACUR Roth Capital Affirms Buy On Acura Pharmaceuticals Following NIDA Grant http://www.smarteranalyst.com/2014/08/28/roth-capital-affirms-buy-on-acura-pharmaceuticals-following-nida-grant/
$SWHC Despite Near Term Pain, Our LT Outlook For S&W Remains Largely Unchanged, Says Wedbush http://www.smarteranalyst.com/2014/08/27/despite-near-term-pain-our-lt-outlook-for-sw-remains-largely-unchanged-says-wedbush/
$SWHC Despite Near Term Pain, Our LT Outlook For S&W Remains Largely Unchanged, Says Wedbush http://www.smarteranalyst.com/2014/08/27/despite-near-term-pain-our-lt-outlook-for-sw-remains-largely-unchanged-says-wedbush/
$YHOO Cantor Fitzgerald Maintains Buy On Yahoo Following Alibaba 2Q:CY14 Results http://www.smarteranalyst.com/2014/08/27/cantor-fitzgerald-maintains-buy-on-yahoo-following-alibaba-2qcy14-results/
$YHOO Cantor Fitzgerald Maintains Buy On Yahoo Following Alibaba 2Q:CY14 Results http://www.smarteranalyst.com/2014/08/27/cantor-fitzgerald-maintains-buy-on-yahoo-following-alibaba-2qcy14-results/
Cree: Downside Is Fairly Well Protected Around The $49 Level, Says Wedbush http://www.smarteranalyst.com/2014/08/27/cree-downside-is-fairly-well-protected-around-the-49-level-says-wedbush/
Roth Capital Reiterates Buy On Nektar Therapeutics; Sees 46% Potential Upside http://www.smarteranalyst.com/2014/08/25/william-blair-maintains-outperform-on-el-pollo-loco-following-20-new-franchise-agreements/
Trina Solar: Sentiment In The Stock May Remain Weak Over The Near-Term, Says Roth Capital http://www.smarteranalyst.com/2014/08/27/trina-solar-sentiment-in-the-stock-may-remain-weak-over-the-near-term-says-roth-capital/
We Remain Constructive On Shares Of ADEP Over A Longer Time Horizon, Says Roth Capital http://www.smarteranalyst.com/2014/08/27/we-remain-constructive-on-shares-of-adep-over-a-longer-time-horizon-says-roth-capital/
Analyst Vs. Blogger: Burger King – Who Do You Side With? http://www.smarteranalyst.com/2014/08/26/analyst-vs-blogger-burger-king-who-do-you-side-with/
$EXAS Exact Sciences: We Expect Volatility To Continue But Remain Bullish On The Stock, Says William Blair http://www.smarteranalyst.com/2014/08/25/exact-sciences-we-expect-volatility-to-continue-but-remain-bullish-on-the-stock-says-william-blair/
$ITMN William Blair Raises InterMune’s Price Target To $74 Following Acquisition By Roche http://www.smarteranalyst.com/2014/08/25/william-blair-raises-intermunes-price-target-to-74-following-acquisition-by-roche/
$ITMN William Blair Raises InterMune’s Price Target To $74 Following Acquisition By Roche http://www.smarteranalyst.com/2014/08/25/william-blair-raises-intermunes-price-target-to-74-following-acquisition-by-roche/
William Blair Raises InterMune’s Price Target To $74 Following Acquisition By Roche http://www.smarteranalyst.com/2014/08/25/william-blair-raises-intermunes-price-target-to-74-following-acquisition-by-roche/
Roth Capital Maintains Buy On Lannett Following Earnings Preannouncement http://www.smarteranalyst.com/2014/08/25/roth-capital-maintains-buy-on-lannett-following-earnings-preannouncement/
$ADHD Roth Capital Maintains Buy On Alcobra Following First Patient Enrollment In Fragile X Study http://www.smarteranalyst.com/2014/08/25/roth-capital-maintains-buy-on-alcobra-following-first-patient-enrollment-in-fragile-x-study/
$ADHD Roth Capital Maintains Buy On Alcobra Following First Patient Enrollment In Fragile X Study http://www.smarteranalyst.com/2014/08/25/roth-capital-maintains-buy-on-alcobra-following-first-patient-enrollment-in-fragile-x-study/
We Remain Neutral On Lowe’s Companies As We Continue To See 2H Sales Risk, Says Wedbush http://www.smarteranalyst.com/2014/08/25/we-remain-neutral-on-lowes-companies-as-we-continue-to-see-2h-sales-risk-says-wedbush/
$XON Griffin Securities Maintains Buy On Intrexon; Sees 99% Potential Upside http://www.smarteranalyst.com/2014/08/25/griffin-securities-maintains-buy-on-intrexon-sees-potential-105-upside/
William Blair Maintains Outperform On El Pollo Loco Following 20 New Franchise Agreements http://www.smarteranalyst.com/2014/08/25/william-blair-maintains-outperform-on-el-pollo-loco-following-20-new-franchise-agreements/
Analyst Vs. Analyst: Intuit Inc. - Who Do You Side With? http://www.smarteranalyst.com/2014/08/25/analyst-vs-analyst-intuit-inc-who-do-you-side-with-2/
Wedbush Maintains Neutral On Home Depot But Raises PT To $90 http://www.smarteranalyst.com/2014/08/25/wedbush-maintains-neutral-on-home-depot-but-raises-pt-to-90/
Canaccord Reiterates Buy On Keurig Green Following Licensing Agreement With Kraft Foods http://www.smarteranalyst.com/2014/08/25/canaccord-reiterates-buy-on-keurig-green-following-licensing-agreement-with-kraft-foods/
Aspen Technology: This Is A Reasonably Compelling Entry Point, Says Canaccord http://www.smarteranalyst.com/2014/08/25/aspen-technology-this-is-a-reasonably-compelling-entry-point-says-canaccord/